Thus, lower level of IFN-γ/IL-2 producing CD4+ T cells of IN_in_r1-immunized mice may have indicated higher levels of CD4+ T cells producing IFN-γ/TNF-α, with the latter, or both events, contributing to a better protection of these mice against tumor challenge. The gene discussed is IFNG; the disease is neoplasm.